Effect of Marijuana on Some Cardiac Biomarkers among Smokers in Southwest Nigeria
J. Sado
Department of Medical Laboratory Science, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria.
A. A. Salawu *
Department of Chemical Pathology, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria.
S. K. Mosaku
Department of Psychiatry, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.
T. W. Oloyede
Department of Chemical Pathology, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria.
S. A. Ojedokun
Department Chemical Pathology, Lautech Teaching Hospital, Ogbomoso, Oyo State, Nigeria.
*Author to whom correspondence should be addressed.
Abstract
Background: Marijuana is the oldest and one of the most widely used illicit drugs, the clinical and pharmacological effects of cannabinoids have been recently studied, with much still unknown about the physiologic and pathologic effects. This study aimed to evaluate its cardiovascular effect using some cardiac makers among smokers in Nigeria.
Methods: The study was a comparative design conducted among eighty-eight test and control subjects. Venous blood was collected for AST, LDH and CK-MB. Biodata was obtained via questionnaires with anthropometric and blood pressure measures. Data were analyzed using SPSS version 21 and a significant level was taken at p<0.05.
Results: There was a decrease in systolic and diastolic blood pressure of subjects who use marijuana as observed from earlier studies. There was a significant increase in the levels of these enzymes in marijuana users as compared to non-smokers.
Conclusion: The increase in these cardiac bio-markers, though heralds the pathologic effect of the use of marijuana on the heart, will be most convincing to assay more cardiac markers such as troponin T to buttress these findings.
Keywords: Marijuana, cardiac biomarkers, smokers, Nigeria
How to Cite
References
Osborne GB, Fogel C. Understanding the motivations for recreational marijuana use among adult Canadians. Subst Use Misuse [Internet]. 2008[cited 2023 Sep 24];43(3–4):539–72. Available:https://pubmed.ncbi.nlm.nih.gov/18365950/
Sharma P, Murthy P, Bharath MMS. Chemistry, Metabolism, and Toxicology of Cannabis: Clinical Implications. Iran J Psychiatry [Internet]. 2012 [cited 2023 Sep 24];7(4):149. Available: /pmc/articles/PMC3570572/
Barnett JH, Werners U, Secher SM, Hill KE, Brazil R, Masson K, et al. Substance use in a population-based clinic sample of people with first-episode psychosis. The British Journal of Psychiatry [Internet]. 2007 Jun [cited 2023 Sep 24];190(6):515–20. Available:https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/substance-use-in-a-populationbased-clinic-sample-of-people-with-firstepisode-psychosis/ACE0E09BA23E61AFCD0AA1E2D650CF58
Fergusson DM, Horwood LJ, Lynskey MT, Madden PAF. Early reactions to cannabis predict later dependence. Arch Gen Psychiatry. 2003 Oct 1;60(10):1033–9.
UNODC - Bulletin on Narcotics - 1972 Issue 2 - 002 [Internet]. [cited 2023 Sep 24]. Available:https://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1972-01-01_2_page003.html
Nelson EUE. Consumption, not decriminalization: How Nigerian drug dealers/users account for cannabis harms. International Journal of Drug Policy. 2022;106.
Yarnell S. The use of medicinal marijuana for posttraumatic stress disorder: A review of the current literature. Prim Care Companion J Clin Psychiatry. 2015;17(3).
Page RL, Allen LA, Kloner RA, Carriker CR, Martel C, Morris AA, et al. Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. 2020 Sep 8;142(10):E131–52.
Subramaniam VN, Menezes AR, DeSchutter A, Lavie CJ. The Cardiovascular Effects of Marijuana: Are the Potential Adverse Effects Worth the High? Mo Med [Internet]. 2019 Mar 1 [cited 2023 Sep 24];116(2):146. Available: /pmc/articles/PMC6461323/
Metabolic Syndrome and Cannabinoids – Nature’s Breakthrough [Internet]. [cited 2023 Sep 24]. Available:https://naturesbreakthrough.com/blogs/news/metabolic-syndrome-and-cannabinoids
Vallée A. Association between cannabis use and blood pressure levels according to comorbidities and socioeconomic status. Scientific Reports 2023 13:1 [Internet]. 2023 Feb 5 [cited 2023 Sep 24];13(1):1–13. Available:https://www.nature.com/articles/s41598-022-22841-6
Alshaarawy O, Elbaz HA. Cannabis Use and Blood Pressure Levels: United States National Health and Nutrition Examination Survey, 2005–2012. J Hypertens [Internet]. 2016 Aug 1 [cited 2023 Sep 24];34(8):1507. Available: /pmc/articles/PMC5237375/
Vázquez-Bourgon J, Ortiz-García de la Foz V, Suarez-Pereira I, Iruzubieta P, Arias-Loste MT, Setién-Suero E, et al. Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis. Data Brief. 2019 Dec 1;27.
Kaufmann R, Aqua K, Lombardo J, Lee M. Observed Impact of Long-Term Consumption of Oral Cannabidiol on Liver Function in Healthy Adults. Cannabis Cannabinoid Res. 2023 Feb 1;8(1):148–54.
Wayangankar SA, Dasari TW, Lozano PM, Beckman KJ. A Case of Critical Aortic Stenosis Masquerading as Acute Coronary Syndrome. Cardiol Res Pract [Internet]. 2010 [cited 2023 Sep 24];2010(1). Available: /pmc/articles/PMC2913510/